The Need for Individualized Risk Assessment in Cardiovascular Disease.

Lim, Hui Yin; Burrell, Louise M; Brook, Rowena; Nandurkar, Harshal H; Donnan, Geoffrey; Ho, Prahlad

Lim, Hui Yin; Burrell, Louise M; Brook, Rowena; Nandurkar, Harshal H; Donnan, Geoffrey; Ho, Prahlad.

Afiliação

Lim HY; Northern Pathology Victoria, Northern Health, Epping, Melbourne, VIC 3076, Australia.
Burrell LM; Department of Hematology, Northern Health, Epping, Melbourne, VIC 3076, Australia.
Brook R; Australian Centre for Blood Diseases, Monash University, Melbourne, VIC 3004, Australia.
Nandurkar HH; Department of Medicine, Northern Health, University of Melbourne, Epping, Melbourne, VIC 3076, Australia.
Donnan G; Department of Medicine, Austin Health, University of Melbourne, Heidelberg, Melbourne, VIC 3084, Australia.
Ho P; Department of Medicine, Austin Health, University of Melbourne, Heidelberg, Melbourne, VIC 3084, Australia.

J Pers Med ; 12(7)2022 Jul 14.

Article em En | MEDLINE | ID: mdl-35887637

Palavras-chave

Virchow's triad; cardiovascular disease; endothelial markers; global coagulation assays; risk assessment

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google